Vergoeding 2019-2023 voor ATC-subgroep J05AG : Niet-nucleoside reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J05AG01 Nevirapine (Viramune ®) | 1.756.900 | 1.508.700 | 1.066.100 | 873.830 | 999.910 |
| J05AG03 Efavirenz | 424.690 | 370.020 | 349.750 | 222.640 | 109.540 |
| J05AG04 Etravirine (Intelence ®) | 598.070 | 498.550 | 427.590 | 396.470 | 347.260 |
| J05AG05 Rilpivirine (Rekambys ®) | 295.320 | 270.420 | 392.020 | 1.174.600 | 2.212.600 |
| J05AG06 Doravirine (Pifeltro ®) | 14.082 | 272.680 | 510.480 | 752.700 | 853.910 |
| Totaal | 3.089.062 | 2.920.370 | 2.745.940 | 3.420.240 | 4.523.220 |